Literature DB >> 12801845

Fainting induces an acute increase in the concentration of plasma factor VIII and von Willebrand factor.

Alessandra Casonato1, Elena Pontara, Antonella Bertomoro, Maria Grazia Cattini, Carmen Soldera, Antonio Girolami.   

Abstract

BACKGROUND AND OBJECTIVES: von Willebrand factor (VWF) is stored in the Weibel-Palade bodies of endothelial cells and may be released in response to different secretion stimuli such as stress, physical exercise, adrenaline, DDAVP and thrombin. DESIGN AND METHODS: We found that fainting can also induce an acute increase in plasma VWF and factor FVIII (FVIII) concentrations, following observations in two patients with von Willebrand's disease (VWD) who experienced a fainting episode during venipuncture for blood collection.
RESULTS: One patient was classified as having type Vicenza VWD, the other as type 1 VWD; both had normal platelet VWF content. After the fainting episode, FVIII and VWF levels were significantly higher than the levels in blood samples collected without stress; mean increases were 4.35-fold for FVIII, 4-fold for VWF:Ag and 5.3-fold for VWF:RCo, with values overshooting the upper limit of the normal range. Moreover, the post-fainting plasma VWF multimer pattern was characterized by a significant increase in all oligomers with the appearance of unusually large VWF multimers, similar to those observed following DDAVP infusion. INTERPRETATION AND
CONCLUSIONS: These findings demonstrate that fainting acts as a stimulus capable of inducing the release of VWF from endothelial cells, and further highlight the role of stress in determining hemostatic states potentially favorable to the development of thrombotic complications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12801845

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  8 in total

1.  Vasovagal fainting as an evolutionary remnant of the fight against hemorrhage.

Authors:  Marcel Levi
Journal:  Clin Auton Res       Date:  2005-04       Impact factor: 4.435

Review 2.  Laboratory testing for von Willebrand disease: toward a mechanism-based classification.

Authors:  Richard Torres; Yuri Fedoriw
Journal:  Clin Lab Med       Date:  2009-06       Impact factor: 1.935

3.  The target of vasovagal syncope is hemostasis and not heart protection.

Authors:  Rolf R Diehl
Journal:  Clin Auton Res       Date:  2017-07-11       Impact factor: 4.435

4.  Quantification of perioperative changes in von Willebrand factor and factor VIII during elective orthopaedic surgery in normal individuals.

Authors:  A Kahlon; J Grabell; A Tuttle; D Engen; W Hopman; D Lillicrap; P James
Journal:  Haemophilia       Date:  2013-05-28       Impact factor: 4.287

5.  The influence of vasovagal response on the coagulation system.

Authors:  Markus Kraemer; Markus Kuepper; Andrea Nebe-vom Stein; Ulrich Sorgenfrei; Rolf R Diehl
Journal:  Clin Auton Res       Date:  2009-07-25       Impact factor: 4.435

Review 6.  Vasovagal Syncope As A Manifestation Of An Evolutionary Selected Trait.

Authors:  Paolo Alboni; Marco Alboni
Journal:  J Atr Fibrillation       Date:  2014-08-31

7.  Procoagulatory changes induced by head-up tilt test in patients with syncope: observational study.

Authors:  Artur Fedorowski; Nazim Isma; Viktor Hamrefors; Karin Strandberg; Richard Sutton
Journal:  Thromb J       Date:  2017-06-20

Review 8.  The origin of vasovagal syncope: to protect the heart or to escape predation?

Authors:  Paolo Alboni; Marco Alboni; Giorgio Bertorelle
Journal:  Clin Auton Res       Date:  2008-06-30       Impact factor: 5.625

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.